Daniel C. Norman, the Executive Vice President and President of Asia at Nature's Sunshine Products Inc., has reported several transactions involving the company's common shares, according to a recent SEC filing. This update is significant as it sheds light on the executive's compensation structure, which is tied to the company's financial performance.

Background

Nature's Sunshine Products Inc. is a company based in Lehi, Utah, primarily engaged in the pharmaceutical preparations industry. The company is known for its health and wellness products, which are distributed through a network of independent distributors. The recent filings indicate that the company has been active in aligning its executive compensation with performance milestones.

What the Filing Says

The SEC filing, dated November 6, 2026, details multiple transactions made by Norman on November 4, 2026. Notably, he acquired 871 shares as part of a performance-based restricted stock unit grant related to an adjusted EBITDA milestone achievement of $46.2 million. Additionally, he disposed of shares to cover tax obligations resulting from the vesting of these units.

"These shares are vested shares resulting from the achievement of an adjusted EBITDA milestone of $46.2M over a rolling 12-month period..."

Overall, Norman's transactions included acquiring a total of 2,804 shares while disposing of 1,136 shares, reflecting a strategic approach to managing his equity in the company.

Impact

This filing may affect various stakeholders, including investors, employees, and competitors in the pharmaceutical preparations sector. The transparency in executive compensation tied to performance metrics could influence how similar companies structure their own compensation packages, potentially leading to a broader industry trend.

What's Next

The filing does not say what happens next.